The Food and Drug Administration (FDA) advisory board unanimously voted Thursday (October 14) to recommend the Moderna COVID-19 vaccine booster to young people aged 65 and over who are at high risk of severe illness. Or medical conditions and complications due to their work.
Now, it is up to the FDA to decide whether to follow the recommendations from the Vaccine and Related Biopharmaceutical Advisory Board.
The FDA does not always follow the recommendations of the Commission, but in many cases it does. According to CNBC.. Following the FDA’s final decision (which may come in a few days), the US Centers for Disease Control and Prevention (CDC) Advisory Board will vote.
According to CNBC, the CDC panel also recommends approval, and if approved by the CDC, booster shots will be available to those who received the Moderna vaccine at least 6 months ago.
The Pfizer / BioNTech vaccine booster shot was approved by the same group a few weeks ago. If approved, the Moderna booster shot will be half the dose of the two Moderna shots given in the original series of vaccinations.
All 19 members of the committee recommended boosters, but some members said Moderna’s data was completely unconvincing that booster shots had enhanced protection or needed them. I did. Reported by CNN.. “The data aren’t complete, but these are extraordinary times and we need to deal with incomplete data,” said Eric Rubin, editor-in-chief of the New England Journal of Medicine and professor at Harvard TH Chan School of Public Health. The doctor says. According to CNN, he said.
The FDA’s advisory board will also vote on Friday (October 15) to recommend booster shots of the Johnson & Johnson COVID-19 vaccine, the third COVID-19 vaccine approved in the United States. According to the New York Times..
Originally published in Live Science.
FDA Advisory Board Votes to Recommend Moderna COVID-19 Vaccine Booster
Source link FDA Advisory Board Votes to Recommend Moderna COVID-19 Vaccine Booster